Applied DNA Sciences regains Nasdaq compliance
Seeking Alpha News (Wed, 18-Sep 9:18 AM ET)
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
ACCESSWIRE (Wed, 18-Sep 9:01 AM ET)
ACCESSWIRE (Tue, 17-Sep 11:50 AM ET)
ACCESSWIRE (Tue, 17-Sep 11:48 AM ET)
Applied DNA Launches Mpox Clade I and Clade II Testing Service
ACCESSWIRE (Wed, 11-Sep 9:03 AM ET)
Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan
ACCESSWIRE (Wed, 4-Sep 9:03 AM ET)
ACCESSWIRE (Fri, 23-Aug 9:01 AM ET)
ACCESSWIRE (Mon, 19-Aug 3:26 PM ET)
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
ACCESSWIRE (Thu, 8-Aug 4:14 PM ET)
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
ACCESSWIRE (Wed, 7-Aug 8:07 AM ET)
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Applied Dna Sciences trades on the NASDAQ stock market under the symbol APDN.
As of September 18, 2024, APDN stock price declined to $1.32 with 855,881 million shares trading.
APDN has a beta of 4.19, meaning it tends to be more sensitive to market movements. APDN has a correlation of 0.07 to the broad based SPY ETF.
APDN has a market cap of $13.60 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, APDN stock traded as high as $147.00 and as low as $.31.
The top ETF exchange traded funds that APDN belongs to (by Net Assets): VXF.
APDN has underperformed the market in the last year with a price return of -95.4% while the SPY ETF gained +27.8%. However, in the short term, APDN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +187.0% vs +2.9% return in SPY. But in the last 2 weeks, APDN shares have been beat by the market, returning -13.2% compared to an SPY return of +1.7%.
APDN support price is $1.14 and resistance is $1.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APDN stock will trade within this expected range on the day.